← Open Payments lookup

MOLLY BABL: Open Payments

NPI 1407255086 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$852 in 36 payments from 10 companies in 2025. Trend: 2023 $1,081 · 2024 $920 · 2025 $852

Food & beverage: $852
CompanyPaymentsAmount
ABBVIE INC.15$377
AstraZeneca Pharmaceuticals LP6$168
Novo Nordisk Inc5$119
Otsuka America Pharmaceutical, Inc.4$88
Amgen Inc.1$24
E.R. Squibb & Sons, L.L.C.1$17
Boehringer Ingelheim Pharmaceuticals, Inc.1$17
Lilly USA, LLC1$15
Currax Pharmaceuticals LLC1$14
GlaxoSmithKline, LLC.1$14

Products named: VRAYLAR, BREZTRI, REXULTI, Wegovy, QULIPTA, AIRSUPRA, UBRELVY, EVENITY.

Industry payments across NE — which companies pay providers there.